ABEO — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

29.63

Margin Of Safety %

Put/Call OI Ratio

0.27

EPS Next Q Diff

0.05

EPS Last/This Y

-2.25

EPS This/Next Y

1.15

Price

4.82

Target Price

19.57

Analyst Recom

Performance Q

-7.85

Upside

627.7%

Beta

1.25

Ticker: ABEO

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	ABEO	5.16	0.20	0.48	44127
2026-03-10	ABEO	5.14	0.20	0.43	44913
2026-03-11	ABEO	5.01	0.24	0.14	50272
2026-03-12	ABEO	4.96	0.25	0.16	50962
2026-03-13	ABEO	4.95	0.25	0.16	50962
2026-03-17	ABEO	4.77	0.25	0.18	52794
2026-03-18	ABEO	4.56	0.24	0.10	53944
2026-03-20	ABEO	4.47	0.22	0.18	57333
2026-03-25	ABEO	4.42	0.22	0.97	23723
2026-03-26	ABEO	4.34	0.23	0.46	23997
2026-03-27	ABEO	4.29	0.23	1.17	24552
2026-03-30	ABEO	4.24	0.23	2.70	24753
2026-03-31	ABEO	4.49	0.24	0.66	25070
2026-04-01	ABEO	4.59	0.24	1.37	25525
2026-04-06	ABEO	4.77	0.26	4.23	26074
2026-04-07	ABEO	4.82	0.27	6.11	26397
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	ABEO	5.16	-7.6	-	-0.14
2026-03-10	ABEO	5.13	-7.6	-	-0.14
2026-03-11	ABEO	5.01	-7.6	-	-0.14
2026-03-12	ABEO	4.96	-7.6	-	-0.14
2026-03-13	ABEO	4.77	-18.2	-	-0.14
2026-03-17	ABEO	4.76	-18.2	-	-0.14
2026-03-18	ABEO	4.55	-18.2	-	-0.14
2026-03-19	ABEO	4.56	-18.2	-	-0.14
2026-03-20	ABEO	4.47	-63.9	-	-0.91
2026-03-23	ABEO	4.43	-63.9	-	-0.91
2026-03-24	ABEO	4.34	-63.9	-	-0.91
2026-03-25	ABEO	4.42	-63.9	-	-0.91
2026-03-26	ABEO	4.33	-63.9	-	-0.91
2026-03-27	ABEO	4.30	-63.9	-	-0.91
2026-03-30	ABEO	4.24	-63.9	-	-0.91
2026-03-31	ABEO	4.49	-63.9	-	-0.91
2026-04-01	ABEO	4.58	-63.9	-	-0.91
2026-04-02	ABEO	4.83	-63.9	-	-0.91
2026-04-06	ABEO	4.78	-63.9	-	-0.91
2026-04-07	ABEO	4.82	-63.9	-	-0.91
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	ABEO	-4.98	6.52	28.27
2026-03-10	ABEO	-4.98	6.52	28.27
2026-03-11	ABEO	-4.98	6.52	26.96
2026-03-12	ABEO	-4.98	6.52	26.96
2026-03-13	ABEO	-4.98	6.52	26.96
2026-03-18	ABEO	-4.99	6.62	26.96
2026-03-19	ABEO	-4.99	6.62	26.96
2026-03-20	ABEO	-4.75	6.62	25.61
2026-03-23	ABEO	-4.74	6.26	25.61
2026-03-24	ABEO	-4.74	6.26	25.61
2026-03-25	ABEO	-4.74	6.26	29.63
2026-03-26	ABEO	-4.74	6.26	29.63
2026-03-27	ABEO	-4.74	6.26	29.63
2026-03-30	ABEO	-4.74	6.26	29.63
2026-03-31	ABEO	-4.74	6.26	29.63
2026-04-01	ABEO	-5.18	6.26	29.63
2026-04-02	ABEO	-4.25	6.26	29.63
2026-04-06	ABEO	-4.25	6.74	29.63
2026-04-07	ABEO	-4.25	6.74	29.63
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.34

Avg. EPS Est. Current Quarter

-0.39

Avg. EPS Est. Next Quarter

-0.29

Insider Transactions

-4.25

Institutional Transactions

6.74

Beta

1.25

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.6

Max Drawdown 5-Year %

-95.6

Target Price

19.57

P/E

4.82

Forward P/E

35.63

PEG

8.82

P/S

47.15

P/B

1.66

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

-0.91

EPS Next Y. (Est.)

0.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1223.08

Relative Volume

0.8

Return on Equity vs Sector %

17.2

Return on Equity vs Industry %

33.8

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.84

EBIT Estimation

◆ ABEO Healthcare

$4.81

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

7/15

Valuation

15/20

TP/AR

2/10

Options

7/10

RSI

53.6

Range 1M

56%

Sup Dist

2.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

11/30

Estimates

3/20

Inst/Vol

6/15

Options

5/10

EPS Yr

-173.1%

EPS NY

118.3%

52W%

25.2%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +141% upside

Quality

23/30

Valuation

18/30

Growth

7/25

Stability

8/10

LT Trend

1/5

Upside

+141%

Quality

Abeona Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 226

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.

ABEO

Latest News

—

Caricamento notizie per ABEO…

stock quote shares ABEO – Abeona Therapeutics Inc Stock Price stock today

news today ABEO – Abeona Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch ABEO – Abeona Therapeutics Inc yahoo finance google finance

stock history ABEO – Abeona Therapeutics Inc invest stock market

stock prices ABEO premarket after hours

ticker ABEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y